LH Stock Ownership Activity
LABORATORY CRP OF AMER HLDGS 13F holders
No value investing guru has made any change to the LABORATORY CRP OF AMER HLDGS (LH) position according to the gurus' latest SEC quarterly report(s).
Which gurus or hedge funds are buying LH now?
According to the latest SEC filing(s) LABORATORY CRP OF AMER HLDGS (LH) has not been purchased by any super investor.
To see more about who is investing in LABORATORY CRP OF AMER HLDGS (LH), please go to the LH ownership page.
2024 Q2
(5 results)
Current price: $250.94
14.87%
AVG reported price*: $218.46
2024 Q1
(1 result)
Current price: $250.94
14.87%
Reported price*: $218.46
2023 Q4
(3 results)
Current price: $250.94
10.41%
AVG reported price*: $227.29
2023 Q3
(1 result)
Current price: $250.94
24.81%
Reported price*: $201.05
2023 Q2
(4 results)
Current price: $250.94
6.47%
AVG reported price*: $235.68
2023 Q1
(3 results)
Current price: $250.94
9.38%
AVG reported price*: $229.42
2022 Q4
(4 results)
Current price: $250.94
5.22%
AVG reported price*: $238.48
2022 Q3
(3 results)
Current price: $250.94
22.53%
AVG reported price*: $204.80
2022 Q2
(5 results)
Current price: $250.94
7.08%
AVG reported price*: $234.35
2022 Q1
(2 results)
Current price: $250.94
4.83%
AVG reported price*: $263.67
2021 Q4
(5 results)
Current price: $250.94
20.14%
AVG reported price*: $314.21
2021 Q3
(5 results)
Current price: $250.94
10.84%
AVG reported price*: $281.44
2021 Q2
(5 results)
Current price: $250.94
9.03%
AVG reported price*: $275.85
2021 Q1
(4 results)
Current price: $250.94
1.60%
AVG reported price*: $255.03
Shares, change to shares, sold shares - split-adjusted.
Reported price - this doesn't represent the actual buy or sell price.
It is the split-adjusted price of the security as of the last day of the reported period.
Value or Price - If the security is completely sold out, we show the reported value (or price) prior to the actual period.